secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEX CORP /DE/ (IEX)
CIK:        0000832101
Form:       8-K
Filed at:   2022-02-02T23:59:59+00:00
Accession:  0000832101-22-000002
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IDEX reports record Q4 EPS $1.55, full-year EPS $5.88; acquires Nexsight for $120M; guides FY22 adj EPS $7.33-$7.63
--------------------------------------------------------------------------------

- Record Q4 EPS $1.55 on sales $714.8M (+16% overall, +11% organic vs Q4 2020); full year EPS $5.88 (+19%).
- Full year sales $2.8B (+18%); adjusted EPS $6.30 (+21%); record Q4 orders $795.3M (+17%).
- Acquired Nexsight (Envirosight, WinCan, MyTana, Pipeline Renewal Technologies) for $120M cash; expected close Q1 2022.
- FY22 guidance: organic sales growth 5-8%; GAAP EPS $6.70-$7.00, adjusted EPS $7.33-$7.63 under revised definition.
- Health & Science Technologies led with Q4 sales +25% (+16% organic); segment margin up 210 bps to 25.8%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/832101/000083210122000002/0000832101-22-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/832101/000083210122000002/iex-20220201.htm
  HTML page:      https://secwatch.observer/filing/0000832101-22-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer